Healthcare -
Biotechnology - NASDAQ - US
$ 6.74
2.43 %
$ 686 M
Market Cap
-14.98
P/E
TRVI - RESEARCH & DEVELOPMENT
Research & Development TRVI - Trevi Therapeutics, Inc.
39.4 M
LAST VALUE
40.90%
2 YEAR CAGR
15.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR